Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


At, with and beyond risk: expectations of living with the possibility of future dementia.

Milne R, Diaz A, Badger S, Bunnik E, Fauria K, Wells K.

Sociol Health Illn. 2018 Jul;40(6):969-987. doi: 10.1111/1467-9566.12731. Epub 2018 Apr 16.


Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.

Cacciaglia R, Molinuevo JL, Falcón C, Brugulat-Serrat A, Sánchez-Benavides G, Gramunt N, Esteller M, Morán S, Minguillón C, Fauria K, Gispert JD; ALFA study.

Alzheimers Dement. 2018 Jul;14(7):902-912. doi: 10.1016/j.jalz.2018.01.016. Epub 2018 Mar 28.


Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.

Milne R, Bunnik E, Diaz A, Richard E, Badger S, Gove D, Georges J, Fauria K, Molinuevo JL, Wells K, Ritchie C, Brayne C.

J Alzheimers Dis. 2018;62(2):487-498. doi: 10.3233/JAD-170813.


The largest deep-ocean silicic volcanic eruption of the past century.

Carey R, Soule SA, Manga M, White J, McPhie J, Wysoczanski R, Jutzeler M, Tani K, Yoerger D, Fornari D, Caratori-Tontini F, Houghton B, Mitchell S, Ikegami F, Conway C, Murch A, Fauria K, Jones M, Cahalan R, McKenzie W.

Sci Adv. 2018 Jan 10;4(1):e1701121. doi: 10.1126/sciadv.1701121. eCollection 2018 Jan.


Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.

Rojas S, Brugulat-Serrat A, Bargalló N, Minguillón C, Tucholka A, Falcon C, Carvalho A, Morán S, Esteller M, Gramunt N, Fauria K, Camí J, Molinuevo JL, Gispert JD.

J Cereb Blood Flow Metab. 2018 Feb;38(2):250-261. doi: 10.1177/0271678X17707397. Epub 2017 May 11.


Incidental findings on brain MRI of cognitively normal first-degree descendants of patients with Alzheimer's disease: a cross-sectional analysis from the ALFA (Alzheimer and Families) project.

Brugulat-Serrat A, Rojas S, Bargalló N, Conesa G, Minguillón C, Fauria K, Gramunt N, Molinuevo JL, Gispert JD.

BMJ Open. 2017 Mar 24;7(3):e013215. doi: 10.1136/bmjopen-2016-013215.


Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort.

Sánchez-Benavides G, Gispert JD, Fauria K, Molinuevo JL, Gramunt N.

Alzheimers Dement (Amst). 2016 Aug 30;4:149-158. eCollection 2016.


The Memory Binding Test: Development of Two Alternate Forms into Spanish and Catalan.

Gramunt N, Sánchez-Benavides G, Buschke H, Diéguez-Vide F, Peña-Casanova J, Masramon X, Fauria K, Gispert JD, Molinuevo JL.

J Alzheimers Dis. 2016 Mar 5;52(1):283-93. doi: 10.3233/JAD-151175.


The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's disease.

Molinuevo JL, Gramunt N, Gispert JD, Fauria K, Esteller M, Minguillon C, Sánchez-Benavides G, Huesa G, Morán S, Dal-Ré R, Camí J.

Alzheimers Dement (N Y). 2016 Mar 3;2(2):82-92. doi: 10.1016/j.trci.2016.02.003. eCollection 2016 Jun.


Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.

Gramunt N, Sánchez-Benavides G, Buschke H, Lipton RB, Masramon X, Gispert JD, Peña-Casanova J, Fauria K, Molinuevo JL.

J Alzheimers Dis. 2016;50(4):999-1010. doi: 10.3233/JAD-150776.


Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer's and Family).

Gramunt N, Buschke H, Sánchez-Benavides G, Lipton RB, Peña-Casanova J, Diéguez-Vide F, Masramon X, Gispert JD, Fauria K, Camí J, Molinuevo JL.

J Alzheimers Dis. 2015;48(3):613-25. doi: 10.3233/JAD-150237.


18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.

Gebhart G, Gámez C, Holmes E, Robles J, Garcia C, Cortés M, de Azambuja E, Fauria K, Van Dooren V, Aktan G, Coccia-Portugal MA, Kim SB, Vuylsteke P, Cure H, Eidtmann H, Baselga J, Piccart M, Flamen P, Di Cosimo S.

J Nucl Med. 2013 Nov;54(11):1862-8. doi: 10.2967/jnumed.112.119271. Epub 2013 Oct 3.


Clinical observational research on Alzheimer's disease: what clinical trial registries can tell.

Dal-Ré R, Fauria K, Gramunt N, Molinuevo JL.

J Alzheimers Dis. 2013;34(1):183-90. doi: 10.3233/JAD-121525.


Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Baselga J, Bradbury I, Eidtmann H, Di Cosimo S, de Azambuja E, Aura C, Gómez H, Dinh P, Fauria K, Van Dooren V, Aktan G, Goldhirsch A, Chang TW, Horváth Z, Coccia-Portugal M, Domont J, Tseng LM, Kunz G, Sohn JH, Semiglazov V, Lerzo G, Palacova M, Probachai V, Pusztai L, Untch M, Gelber RD, Piccart-Gebhart M; NeoALTTO Study Team.

Lancet. 2012 Feb 18;379(9816):633-40. doi: 10.1016/S0140-6736(11)61847-3. Epub 2012 Jan 17. Erratum in: Lancet. 2012 Feb 18;379(9816):616. Dosage error in published abstract; MEDLINE/PubMed abstract corrected.


The influence of beacon-aiming on the routes of wood ants.

Graham P, Fauria K, Collett TS.

J Exp Biol. 2003 Feb;206(Pt 3):535-41.


Learning speed and contextual isolation in bumblebees.

Fauria K, Dale K, Colborn M, Collett TS.

J Exp Biol. 2002 Apr;205(Pt 7):1009-18.


The binding of visual patterns in bumblebees.

Fauria K, Colborn M, Collett TS.

Curr Biol. 2000 Jul 27-Aug 10;10(15):935-8.

Supplemental Content

Loading ...
Support Center